In Conversation With... Bernardo Goulart Listen To The Lancet Oncology podcast

Artwork

Cancer Tumour Chemotherapy Radiotherapy Surgery Research Trial Study Drug Metastatic Palliative Health and Well-Being Oncology Science Medicine Podcasting Education Lancet Lancet Oncology

Konten disediakan oleh The Lancet and The Lancet Oncology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh The Lancet and The Lancet Oncology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Listen to The Lancet Oncology « »
In conversation with... Bernardo Goulart

7M ago 11:22

Bagikan

MP3•Beranda episode

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 30, 2024 13:11 (21d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Konten disediakan oleh The Lancet and The Lancet Oncology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh The Lancet and The Lancet Oncology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer.

… continue reading

203 episode

#Cancer #Tumour #Chemotherapy #Radiotherapy #Surgery #Research #Trial #Study #Drug #Metastatic #Palliative #Health and Well-Being #Oncology #Science #Medicine #Podcasting Education #Lancet #Lancet Oncology

Artwork

In conversation with... Bernardo Goulart

Listen to The Lancet Oncology

131 subscribers

published 7M ago

Bagikan

MP3•Beranda episode

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 30, 2024 13:11 (21d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Konten disediakan oleh The Lancet and The Lancet Oncology. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh The Lancet and The Lancet Oncology atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Dr Bernardo Goulart (US Food and Drug Administration) discusses his paper on correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer.

… continue reading

203 episode

#Cancer #Tumour #Chemotherapy #Radiotherapy #Surgery #Research #Trial #Study #Drug #Metastatic #Palliative #Health and Well-Being #Oncology #Science #Medicine #Podcasting Education #Lancet #Lancet Oncology

Semua episode

×

Selamat datang di Player FM!

Player FM memindai web untuk mencari podcast berkualitas tinggi untuk Anda nikmati saat ini. Ini adalah aplikasi podcast terbaik dan bekerja untuk Android, iPhone, dan web. Daftar untuk menyinkronkan langganan di seluruh perangkat.

Dengarkan 500+ topik